136 related articles for article (PubMed ID: 3101712)
21. Hemophiliac immunodeficiency: influence of exposure to factor VIII concentrate, LAV/HTLV-III, and herpesviruses.
Sullivan JL; Brewster FE; Brettler DB; Forsberg AD; Cheeseman SH; Byron KS; Baker SM; Willitts DL; Lew RA; Levine PH
J Pediatr; 1986 Apr; 108(4):504-10. PubMed ID: 3007715
[TBL] [Abstract][Full Text] [Related]
22. [Immunological status of hemophiliacs: study of blood T-lymphocyte populations, serum immunoglobulins, and the prevalence of anti-LAV antibodies].
Aymard JP; Janot C; Briquel ME; André E; Schooneman F; Vigneron C; Legras B; Alexandre P; Streiff F
Pathol Biol (Paris); 1985 Dec; 33(10):951-6. PubMed ID: 3005949
[TBL] [Abstract][Full Text] [Related]
23. Detection of antibodies to HTLV-I and -III in sera from Japanese hemophiliacs.
Abe T; Kinoshita T; Matsuda J; Ryu T; Ting RC; Aoki T; Robert-Guroff M; Miyakoshi H; Gallo RC
Cancer Res; 1985 Sep; 45(9 Suppl):4621s-4623s. PubMed ID: 2990696
[TBL] [Abstract][Full Text] [Related]
24. Anti-HTLV-III and anti-HTLV-I antibodies and T cell subsets in hemophiliacs living in HTLV-I endemic and nonendemic areas of Japan.
Hattori T; Ikematsu S; Chosa T; Yamamoto S; Matsuoka M; Fukutake K; Robert-Guroff M; Takatsuki K
Acta Haematol; 1987; 77(1):25-9. PubMed ID: 2883800
[TBL] [Abstract][Full Text] [Related]
25. LAV/HTLV-III seroconversion and disease in hemophiliacs treated in France.
Mathez D; Leibovitch J; Sultan Y; Maisonneuve P
N Engl J Med; 1986 Jan; 314(2):118-9. PubMed ID: 3079879
[No Abstract] [Full Text] [Related]
26. Lymphadenopathy-associated virus antibodies and T cells in hemophiliacs treated with cryoprecipitate or concentrate.
Gjerset GF; McGrady G; Counts RB; Martin PJ; Jason J; Kennedy S; Evatt B; Hansen JA
Blood; 1985 Sep; 66(3):718-20. PubMed ID: 2992642
[TBL] [Abstract][Full Text] [Related]
27. Natural history of acquired immunodeficiency syndrome in hemophilic patients.
Kim HC; Nahum K; Raska K; Gocke DJ; Kosmin M; Karp GI; Saidi P
Am J Hematol; 1987 Feb; 24(2):169-76. PubMed ID: 3101490
[TBL] [Abstract][Full Text] [Related]
28. [HTLV-III antibodies and immunologic changes in hemophilic children. Prevalence of HTLV-III antibodies in hemophilic children and their relatives living in the same household].
Zenz W; Muntean W; Teubl I; Beaufort F; Heinz FX
Padiatr Padol; 1987; 22(1):33-41. PubMed ID: 3108827
[TBL] [Abstract][Full Text] [Related]
29. A study of lymphocyte populations and subpopulations in hemophiliacs and their relationships with age and consumption of lyophilized factor VIII concentrates.
Aznar JA; Carbonell F; Jorquera JI; Carmona E; Sánchez-Cuenca JM; Trénor A; de Andrés-Medina R; González-Molina A
Ric Clin Lab; 1985; 15(4):315-21. PubMed ID: 3938863
[TBL] [Abstract][Full Text] [Related]
30. Antibodies to HIV in Israeli hemophiliacs: relationship between serological profile and disease development.
Orgad S; Malone G; Zaizov R; Marinowitz U; McLane MF; Umiel T; Cohen IJ; Vogel R; Cohen-Avishai O; Ramot B
AIDS Res Hum Retroviruses; 1987; 3(3):323-32. PubMed ID: 3124874
[TBL] [Abstract][Full Text] [Related]
31. Time relationship of immune changes to HTLV-III/LAV seroconversion in patients with hemophilia.
Knutsen AP; Bouhasin JD; Lawrence DN; Roodman ST; Mueller KR; McDougal JS; Joist JH
Ann Allergy; 1986 Nov; 57(5):376-84. PubMed ID: 2946253
[TBL] [Abstract][Full Text] [Related]
32. HTLV-III antibody and T-cell subset ratios in haemophiliacs and their spouses.
McVerry BA; Machin SJ; Galloway MJ; McCarthy K; Evans P; Barnes RM; Turner GC; Cheingsong-Popov R; Tedder RS; Winter M
Br J Haematol; 1986 Jun; 63(2):347-52. PubMed ID: 3013274
[TBL] [Abstract][Full Text] [Related]
33. Antibodies reactive with human T cell leukemia viruses in the serum of hemophiliacs receiving factor VIII concentrate.
Goedert JJ; Sarngadharan MG; Eyster ME; Weiss SH; Bodner AJ; Gallo RC; Blattner WA
Blood; 1985 Feb; 65(2):492-5. PubMed ID: 2981592
[TBL] [Abstract][Full Text] [Related]
34. [Epidemiology of infection by LAV/HTLV-III virus in hemophiliacs multitransfused in France. Results of a survey conducted by 28 hemophilia centers].
Sultan Y
Nouv Rev Fr Hematol (1978); 1986; 28(5):327-9. PubMed ID: 3643509
[TBL] [Abstract][Full Text] [Related]
35. Antibodies to human T-cell lymphotropic virus-I membrane antigens and inverted T4/T8 ratios in hemophiliacs.
Kloster BE; Tomar RH; Stockman JA; Lamberson HV; Merl SA; John PA; Groth DM; Poiesz BJ
Am J Clin Pathol; 1985 Apr; 83(4):450-6. PubMed ID: 2984918
[TBL] [Abstract][Full Text] [Related]
36. Natural history of primary infection with LAV in multitransfused patients. By the AIDS-Hemophilia French Study Group.
Blood; 1986 Jul; 68(1):89-94. PubMed ID: 3013344
[TBL] [Abstract][Full Text] [Related]
37. Relation of human T lymphotropic virus type III antibodies to T lymphocyte subset abnormalities in hemophiliac patients.
Hoxie JA; Rackowski JL; Cedarbaum AJ; Hurwitz S; Catalano PM
Am J Med; 1986 Aug; 81(2):201-7. PubMed ID: 3017105
[TBL] [Abstract][Full Text] [Related]
38. HTLV-III/LAV antibody and immune status of household contacts and sexual partners of persons with hemophilia.
Jason JM; McDougal JS; Dixon G; Lawrence DN; Kennedy MS; Hilgartner M; Aledort L; Evatt BL
JAMA; 1986 Jan; 255(2):212-5. PubMed ID: 3001375
[TBL] [Abstract][Full Text] [Related]
39. Defect in B cell function in HTLV III/LAV positive hemophilia patients.
Sjamsoedin-Visser EJ; Heijnen CJ; Zegers BJ; Stoop JW
Blood; 1987 May; 69(5):1388-93. PubMed ID: 2952185
[TBL] [Abstract][Full Text] [Related]
40. [Anti-LAV/HTLV III antibodies in wives of seropositive hemophilic patients].
Bardin JM; Maisonneuve P; Nguyen M; Pinon F; Sultan Y
Presse Med; 1986 Oct; 15(33):1686-7. PubMed ID: 2947123
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
